Empire Financial Management Company »

Rigel Pharmaceuticals shares owned by Empire Financial Management Company

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Empire Financial Management Company from 13F filings

Historical chart of Empire Financial Management Company investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Empire Financial Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Empire Financial Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $280k 193k 1.45

More positions owned by Empire Financial Management Company

Etf Series Solutions Distillate Us (DSTL)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Litman Gregory Funds Trust Imgp Dbi Managed (DBMF)
Alphabet Cap Stk Cl A (GOOGL)
International Business Machines (IBM)
Pacer Fds Tr Globl Cash Etf (GCOW)
Abbott Laboratories (ABT)
Etf Series Solutions Distillate Intnl (DSTX)
John Hancock Exchange Traded Multifactr Sml (JHSC)
Procter & Gamble Company (PG)
Home Depot (HD)
Ea Ser Tr Marketdesk Focus (FDIV)

View all positions for Empire Financial Management Company

Top funds holding Rigel Pharmaceuticals

Soleus Capital Management
Vanguard Group
Jacobs Levy Equity Management
Assenagon Asset Management
CM Management
GSA Capital Partners
Sphera Funds Management
Millennium Management
Charles Schwab Investment Management
Two Sigma Advisers
Thomas Stevens, CFA"
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
Goldman Sachs Group
Squarepoint Ops

View all funds holding Rigel Pharmaceuticals